Belgium· BE-AMP-SAM521155-00
Ivegam-CMV 100 U/ml
A cytomegalovirus immunoglobulin product containing human cytomegalovirus immunoglobulin, registered in Belgium by Centrale Afdeling Voor Fractionering - Departement Central De Fractionnement. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Cytomegalovirus immunoglobulin is registered in 9 of 19 countries.
Countries holding a registration under ATC J06BB09 (cytomegalovirus immunoglobulin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Cytomegalovirus immunoglobulin · ATC J06BB09
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Human Cytomegalovirus Immunoglobulin
- Manufacturer
- Centrale Afdeling Voor Fractionering - Departement Central De Fractionnement
- Country
- Belgium (BE)
- ATC code
- J06BB09
- ATC class
- Cytomegalovirus immunoglobulin
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cytomegalovirus immunoglobulin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCytomegalovirus immunoglobulin human 3g powder for solution for infusion vialsScottish National Blood Transfusion Service
- GermanyCytotect CpBiotest Pharma Gmbh
- SpainMEGALOTECT 100 U/ML SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- CanadaCYTOGAMKI BIOPHARMA LLC
- IrelandMegalotect 100 U/mL solution for infusionBiotest Pharma GmbH
- NetherlandsMegalotect 100 E/ml oplossing voor infusieBiotest Pharma GmbH
- PolandMegalotect CPBiotest Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Cytotect Cp
- Czechia · Cymvigo
- Germany · Cytotect Cp
- Spain · Megalotect
- United Kingdom (Northern Ireland) · Cytotect Cp
- Greece · Megalotect Cp
- Croatia · Cytotect Cp
- Hungary · Cytotect Cp
- Ireland · Megalotect
- Italy · Cytomegatect
- Lithuania · Cymvigo
- Netherlands · Megalotect
- Poland · Megalotect Cp
- Portugal · Megalotect Cp
- Romania · Cytotect Cp
- Slovenia · Megalotect
- Slovakia · Cytotect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/909a22a6-757e-4b44-a426-6abed71d7fb2 GET /v1/drugs/909a22a6-757e-4b44-a426-6abed71d7fb2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Ivegam-CMV 100 U/ml",
"name_fr": "Ivegam-CMV 100 U/ml",
"name_nl": "Ivegam-CMV 100 U/ml",
"amp_code": "SAM521155-00",
"strengths": [
"50.0000",
"50.0000",
"100.0000",
"100.0000"
],
"pack_count": 1,
"substances": [
"Human Cytomegalovirus Immunoglobulin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Cytomegalovirus Immunoglobulin",
"authorisation_numbers": [
"BE521155"
]
}See everything about cytomegalovirus immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.